490 related articles for article (PubMed ID: 21081144)
1. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the effect of donor platelet endothelial cell adhesion molecule 1 polymorphism on the graft-vs.-host disease occurrence in Tunisian recipients of hematopoietic stem cells.
Sellami MH; Torjemane L; Ladeb S; Kaabi H; Ben Ahmed A; Cherif G; Midouni B; Ben Othmane T; Hmida S
Clin Biochem; 2011 Jun; 44(8-9):699-703. PubMed ID: 21349261
[TBL] [Abstract][Full Text] [Related]
3. Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs.
Sellami MH; Torjemane L; Espadas de Arias A; Kaabi H; Ladeb S; Ben Othman T; Poli F; Hmida S
Immunol Invest; 2010; 39(6):611-20. PubMed ID: 20653428
[TBL] [Abstract][Full Text] [Related]
4. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
6. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
[TBL] [Abstract][Full Text] [Related]
7. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
[TBL] [Abstract][Full Text] [Related]
8. Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation.
Goodman RS; Ewing J; Evans PC; Craig J; Poulton K; Dyer PA; Marcus RE; Taylor CJ
Bone Marrow Transplant; 2005 Jul; 36(2):151-6. PubMed ID: 15908974
[TBL] [Abstract][Full Text] [Related]
9. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation.
Stark GL; Dickinson AM; Jackson GH; Taylor PR; Proctor SJ; Middleton PG
Transplantation; 2003 Dec; 76(12):1742-9. PubMed ID: 14688526
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
[TBL] [Abstract][Full Text] [Related]
12. Acute graft-vs.-host disease correlates with the disparity for the PECAM-1 S536N polymorphism only in the HLA-B44-like positive Tunisian recipients of HSCs.
Sellami MH; Ladeb S; Kaabi H; Cherif G; Torjemane L; Othman TB; Hmida S
Cell Immunol; 2010; 265(2):172-8. PubMed ID: 20850712
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
[TBL] [Abstract][Full Text] [Related]
14. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
15. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
[TBL] [Abstract][Full Text] [Related]
16. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
[TBL] [Abstract][Full Text] [Related]
18. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
Bertinetto FE; Dall'Omo AM; Mazzola GA; Rendine S; Berrino M; Bertola L; Magistroni P; Caropreso P; Falda M; Locatelli F; Busca A; Amoroso A
Int J Immunogenet; 2006 Oct; 33(5):375-84. PubMed ID: 16984283
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
20. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
